Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP plus 15% AHA versus 15% AHA alone for facial wrinkles
IRCT20140705018373N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2020
- Countries
- 1
01
Overview
Phase 3, open-label trial of platelet-rich plasma in rhytides (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Intensity of wrinkles, Degree of tissue healing and 2 more. Started Sep 2020; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
rhytides
Beyond the preview
Go deeper on IRCT20140705018373N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140705018373N5.